Prot#EX9536-4773: Effect of Semaglutide 2.4 mg once-weekly on function and symptoms in subjects with obesity-related heart failure with preserved ejection fraction, and type 2 diabetes

Project: Research project

Project Details

StatusActive
Effective start/end date4/11/22 → 4/11/25

Funding

  • Novo Nordisk Inc. (Prot#EX9536-4773)